PUT/MERCK & CO./50/0.1/17.01.25 | Real-time BOERSE MUENCHEN 10:26:02 2024-07-17 am EDT | ||
| 0.008 EUR | -11.11% |
|
| Current month | -10.00% | ||
| 1 month | -35.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 0.008 | -11.11% |
| 24-07-16 | 0.009 | 0.00% |
| 24-07-15 | 0.009 | -30.77% |
| 24-07-12 | 0.013 | +18.18% |
| 24-07-11 | 0.011 | -15.38% |
Real-time BOERSE MUENCHEN
Last update July 17, 2024 at 10:26 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GQ7V5L |
| ISIN | DE000GQ7V5L1 |
| Date issued | 2023-10-20 |
| Strike | 50 $ |
| Maturity | 2025-01-17 (184 Days) |
| Parity | 10 : 1 |
| Emission price | 0.04 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.065 € |
|---|---|
| Lowest since issue | 0.005 € |
| Spread | 0.01 € |
| Spread % | 55.56% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.4
USD
Average target price
142.9
USD
Spread / Average Target
+13.92%
- Stock Market
- Warrants
- Warrant
